Development of a bacteria-nanosapper for the active delivery of ZIF-8 particles containing therapeutic genes for cancer immune therapy
Open Access
- 27 July 2024
- journal article
- research article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 14 (12) , 5418-5434
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Engineered Salmonella inhibits GPX4 expression and induces ferroptosis to suppress glioma growth in vitro and in vivoJournal of Neuro-Oncology, 2023
- IL-2-loaded Polypeptide Nanoparticles for Enhanced Anti-cancer ImmunotherapyChinese Journal of Polymer Science, 2023
- Review on Metal–Organic Framework Classification, Synthetic Approaches, and Influencing Factors: Applications in Energy, Drug Delivery, and Wastewater TreatmentACS Omega, 2022
- Development of a TNF-α-mediated Trojan Horse for bacteria-based cancer therapyMolecular Therapy, 2022
- Targeting of pancreatic cancer cells and stromal cells using engineered oncolytic Salmonella typhimuriumMolecular Therapy, 2022
- Salmonella flagella confer anti-tumor immunological effect via activating Flagellin/TLR5 signalling within tumor microenvironmentActa Pharmaceutica Sinica B, 2021
- Bioengineering Bacterial Vesicle-Coated Polymeric Nanomedicine for Enhanced Cancer Immunotherapy and Metastasis PreventionNano Letters, 2019
- Metal–Organic Frameworks in BiomedicineChemical Reviews, 2011
- -induced macrophage death: the role of caspase-1 in death and inflammationMicrobes and Infection, 2001
- Lysis of Escherichia coli by induction of cloned ϕX174 genesMolecular Genetics and Genomics, 1982